Top Companies in the Home Healthcare

The global market for home healthcare is estimated to be worth USD 309.9 billion in 2025 and is expected to grow to USD 473.8 billion by 2030, at a CAGR of 8.9% during the forecast period. This growth is largely driven by the rapid increase in the elderly population and the rising prevalence of chronic diseases. Elderly adults are more likely to suffer from conditions such as heart disease, diabetes, arthritis, and respiratory illnesses, which often require ongoing treatment and regular monitoring.

Chronic health conditions are becoming more widespread across all age groups due to lifestyle changes, unhealthy diets, and a lack of physical activity. These factors have created a greater demand for personalized, cost-effective care that can be provided in the comfort of one’s home. As a result, home healthcare is emerging as a preferred option, offering convenience, affordability, and improved quality of life for patients managing long-term illnesses.

To know about the assumptions considered for the study download the pdf brochure

In August 2024, Abbott (US) announced a global partnership with Medtronic (Ireland) to collaborate on an integrated continuous glucose monitoring (CGM) system. The partnership combines Abbott’s most advanced, world-leading FreeStyle Libre technology with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems, creating a connected solution for improved diabetes management.

In April 2024, Fresenius Medical Care AG (Germany) introduced the latest generation of its home dialysis system, NxStage Versi HD with GuideMe Software. This upgraded version incorporates advanced features to simplify the dialysis process, enhance patient training, and improve overall user experience.

FRESENIUS MEDICAL CARE AG (GERMANY)

Fresenius Medical Care AG has established a strong presence in the home healthcare market through its subsidiary, Fresenius Medical Care, the world’s largest provider of products and services for people with chronic kidney failure. The company delivers a wide range of home dialysis options, such as peritoneal dialysis (PD) and home hemodialysis (HHD), allowing patients to receive personalized treatments in the comfort of their homes. With a focus on innovation, digital tools, and patient education, Fresenius supports improved health outcomes and helps reduce reliance on hospital-based care.

The company is actively expanding into emerging markets like India by investing in infrastructure, launching awareness campaigns, and offering specialized training programs. Its continued emphasis on home-based therapies and integration of telehealth technologies further solidifies its position as a global leader in home healthcare solutions.

ABBOTT (US)

Abbott holds a significant position in the home healthcare market through its advanced medical devices and diagnostic innovations. Among its key offerings are home-use products like the Libre continuous glucose monitoring (CGM) system, which allows individuals with diabetes to manage their condition more efficiently and independently at home. Abbott focuses heavily on remote patient monitoring, digital health integration, and leveraging data-driven insights to enable timely, personalized care and better health outcomes.

RESMED (US)

ResMed emphasizes digital innovation to help healthcare providers deliver tailored, efficient care while allowing patients to manage their health comfortably from home. This integrated model reduces hospital admissions and improves treatment outcomes, making home therapy more effective and accessible. With operations in over 140 countries, the company continues to expand its global footprint and advance remote care technologies, reinforcing its leadership in the evolving home healthcare industry.

Market Ranking

The home healthcare market is highly competitive, with five main players collectively holding 10-20% of the total market share. Fresenius leads in the dialysis and chronic care segment, while Abbott maintains a strong foothold through its advanced glucose monitoring and cardiac health technologies. Linde plc has carved a niche in respiratory care and home oxygen solutions, supported by its broad medical gas infrastructure. Philips and ResMed strengthen their positions through integrated home monitoring systems and sleep apnea therapy solutions. As demand for at-home chronic disease management and remote patient monitoring continues to grow, leading companies are expanding their digital capabilities and service networks to meet evolving patient and provider expectations. The remaining market is highly fragmented, consisting of regional and emerging players offering niche or cost-effective solutions. This fragmentation presents opportunities for new entrants to establish themselves, especially in underserved markets. Market dynamics are increasingly shaped by aging populations, regulatory shifts favoring decentralized care, and innovations in connected health technologies.

Related Reports:

Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com